4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001415889-25-022750
President and Head of R&D sold 57,054 shares at $2.85 ($162,604)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nagendran Sukumar President and Head of R&D | 2025-08-21 | Sale | −57,054 | $2.85 | $162,604 | 1,165,289 | D |
| Open-market sales · 57,054 sh · avg $2.85 · $162,604 | |||||||
Loading xslF345X05/form4-08222025_040806.xml…